New diabetes clinical trial: Impact GLP-1 Agonists Following Bariatric

Published on: November 14, 2023 at 11:00PM
Conditions: Morbid Obesity; Metabolic Syndrome; Diabetes Mellitus; Hypertension; Obstructive Sleep Apnea of Adult
Interventions: Drug: GLP-1 receptor agonist
Sponsors: University of Missouri-Columbia; American Society for Metabolic and Bariatric Surgery
Not yet recruiting
https://ift.tt/cRT6tbk

Comments